Atherectomy for peripheral arterial disease

Cochrane Database Syst Rev. 2026 Jan 6;1:CD006680. doi: 10.1002/14651858.CD006680.pub4.ABSTRACTRATIONALE: Peripheral arterial disease (PAD) is a condition most commonly caused by atherosclerotic narrowing of lower limb arteries, resulting in intermittent claudication, chronic limb-threatening ischae

S Siddhant Pherwani

Menopause, hormone therapy and cardiovascular risk

Med Sci (Paris). 2025 Dec;41(12):1009-1018. doi: 10.1051/medsci/2025229. Epub 2026 Jan 6.ABSTRACTCardiovascular disease is currently the second leading cause of death among women in France. The menopause period is probably the ideal time to screen for all cardiovascular risk factors. This step is es

G Geneviève Plu-Bureau

Understanding menopause. Pathophysiology of hot flashes

Med Sci (Paris). 2025 Dec;41(12):1004-1008. doi: 10.1051/medsci/2025228. Epub 2026 Jan 6.ABSTRACTMenopause is the permanent cessation of menstruation resulting from the loss of ovarian follicular activity. Although recognized since ancient time, the term "menopause" did not appear until the early 19

F Florence Trémollières

Features of myocardial infarction in women

Med Sci (Paris). 2025 Dec;41(12):975-985. doi: 10.1051/medsci/2025225. Epub 2026 Jan 6.ABSTRACTMyocardial infarction is a major public health concern for women. Hospitalization rates are increasing, particularly among young women. This trend is probably linked to the growing prevalence of cardiovasc

C Charlotte Deloziere

Validity of the International Fitness Scale (IFIS) and its associations with cardiometabolic health and body composition in adults with type 2 diabetes: A cross-sectional study

PLoS One. 2026 Jan 6;21(1):e0339364. doi: 10.1371/journal.pone.0339364. eCollection 2026.ABSTRACTAIMS: To assess the validity of the International Fitness Scale (IFIS) for evaluating cardiorespiratory fitness compared to the 6-minute walk test (6MWT) (criterion validity) and to examine associations

Á Ángel Herraiz-Adillo

Discovery of PPARγ Partial Agonists for Treatment of Type 2 Diabetes Based on an Integrated Virtual Screening Strategy that Combines Fragment Molecular Orbital Calculations, Machine Learning, Molecular Docking, Interaction Fingerprint Filtering, and Molecular Dynamics Simulations

J Phys Chem B. 2026 Jan 6. doi: 10.1021/acs.jpcb.5c06470. Online ahead of print.ABSTRACTPeroxisome proliferator-activated receptor γ (PPARγ) is a key therapeutic target for type 2 diabetes and cardiovascular diseases due to its central role in regulating glucose and lipid metabolism. While full PPAR

Y Yulin Liu